We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stepan Inks Deal to Acquire Surfactant Facility in Mexico
Read MoreHide Full Article
Stepan Company (SCL - Free Report) , a major manufacturer of specialty and intermediate chemicals, has entered into an agreement with BASF Mexicana to acquire its surfactant production facility in Ecatepec, Mexico, with a total capacity of over 50,000 metric tons along with the associated surfactant businesses.
The production facility includes warehouse space of 124,000 square foot, office space and a large laboratory. The acquisition is expected to close in the fourth quarter of 2017, subject to customary closing conditions and fulfilment of certain other requirements. The company also specified that the transaction is expected to create minimal impact on its financial results for 2017. However, the exact financial terms of the deal were not disclosed.
The acquisition is in line with Stepan’s growth strategy in Latin America. It will considerably enhance Stepan’s supply capabilities and market position for surfactants in Mexico. It will also help the company to expand in the Functional and Consumer markets for surfactants.
Stepan’s shares have rallied around 17.6% over the past three months, outperforming the Zacks categorized Chemical-Diversified industry’s 3.1% gain.
Stepan recorded net income of $31.9 million or $1.37 per share in first-quarter 2017 compared with $27.9 million or $1.22 per share reported in the year-ago quarter.
Barring one-time expenses, the adjusted net earnings were $1.36 per share, exceeding the Zacks Consensus Estimate of $1.14.
In the reported quarter, sales from Surfactant rose 4% year over year to $322.6 million. The operating income from segment marginally rose 2.7% year over year to $37.2 million, driven by lower cost of manufacturing.
After reporting a commendable performance in the first quarter, the company provided an optimistic outlook for the remaining year. Stepan is anticipated to benefit from enhanced internal efficiencies, end-market diversification and consistent growth in core polymer markets. Even though higher raw material costs remains a concern, overall earnings are expected to grow this year.
Other top-ranked companies in the basic materials space include The Sherwin-Williams Company (SHW - Free Report) , The Chemours Company (CC - Free Report) and Huntsman Corporation (HUN - Free Report) . All three stocks sport a Zacks Rank #1.
Sherwin-Williams has expected long-term earnings growth rate of 11.4%.
Chemours has expected long-term earnings growth rate of 15.5%.
Huntsman has expected long-term earnings growth rate of 7%.
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
Image: Bigstock
Stepan Inks Deal to Acquire Surfactant Facility in Mexico
Stepan Company (SCL - Free Report) , a major manufacturer of specialty and intermediate chemicals, has entered into an agreement with BASF Mexicana to acquire its surfactant production facility in Ecatepec, Mexico, with a total capacity of over 50,000 metric tons along with the associated surfactant businesses.
The production facility includes warehouse space of 124,000 square foot, office space and a large laboratory. The acquisition is expected to close in the fourth quarter of 2017, subject to customary closing conditions and fulfilment of certain other requirements. The company also specified that the transaction is expected to create minimal impact on its financial results for 2017. However, the exact financial terms of the deal were not disclosed.
The acquisition is in line with Stepan’s growth strategy in Latin America. It will considerably enhance Stepan’s supply capabilities and market position for surfactants in Mexico. It will also help the company to expand in the Functional and Consumer markets for surfactants.
Stepan’s shares have rallied around 17.6% over the past three months, outperforming the Zacks categorized Chemical-Diversified industry’s 3.1% gain.
Stepan recorded net income of $31.9 million or $1.37 per share in first-quarter 2017 compared with $27.9 million or $1.22 per share reported in the year-ago quarter.
Barring one-time expenses, the adjusted net earnings were $1.36 per share, exceeding the Zacks Consensus Estimate of $1.14.
In the reported quarter, sales from Surfactant rose 4% year over year to $322.6 million. The operating income from segment marginally rose 2.7% year over year to $37.2 million, driven by lower cost of manufacturing.
After reporting a commendable performance in the first quarter, the company provided an optimistic outlook for the remaining year. Stepan is anticipated to benefit from enhanced internal efficiencies, end-market diversification and consistent growth in core polymer markets. Even though higher raw material costs remains a concern, overall earnings are expected to grow this year.
Stepan Company Price and Consensus
Stepan Company Price and Consensus | Stepan Company Quote
Stepan currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks Rank #1 stocks here.
Other Stocks to Consider
Other top-ranked companies in the basic materials space include The Sherwin-Williams Company (SHW - Free Report) , The Chemours Company (CC - Free Report) and Huntsman Corporation (HUN - Free Report) . All three stocks sport a Zacks Rank #1.
Sherwin-Williams has expected long-term earnings growth rate of 11.4%.
Chemours has expected long-term earnings growth rate of 15.5%.
Huntsman has expected long-term earnings growth rate of 7%.
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>